CVRx, Inc.
NASDAQ:CVRXMedical - Devices
Healthcare
$2.63 +2.28%
+$0.11 today
- Market cap
- $69.79M
- Beta
- 0.77
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$2.00
52W Low $4.37High $11.30
Volume 0.37M
Average 0.30M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$40.17M
FY 2025 · Annual
Investing Cash Flow
-$580,000.00
FY 2025 · Annual
Financing Cash Flow
$10.52M
FY 2025 · Annual
-81.2% YoYCash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (43.08M) | (41.43M) | (41.2M) | (59.97M) | (53.31M) |
| Depreciation & Amortization | 168K | 412K | 522K | 619K | 756K |
| Deferred Income Tax | 14.62M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.91M | 3.89M | 6.3M | 19.05M | 11.05M |
| Change in Working Capital | (1.58M) | (5.57M) | (4.81M) | 949K | 1M |
| Accounts Receivables | (1.28M) | (2.94M) | (2.05M) | (1.72M) | (1.4M) |
| Inventory | (537K) | (3.08M) | (4.03M) | (1.12M) | (98K) |
| Accounts Payables | 27K | 1.21M | 165K | 698K | 1.25M |
| Other Working Capital | 207K | (761K) | 1.1M | 3.09M | 1.25M |
| Other Non-Cash Items | 229K | 25K | 158K | 203K | 327K |
| Operating Cash Flow | (27.73M) | (42.68M) | (39.02M) | (39.14M) | (40.17M) |
| Capital Expenditures | (1.18M) | (685K) | (591K) | (1.36M) | (580K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (1.18M) | (685K) | (591K) | (1.36M) | (580K) |
| Debt Repayment | (21.3M) | 7.5M | 22.5M | 20M | 0 |
| Common Stock Issued | 133.16M | 771K | 1.66M | 32.52M | 10.52M |
| Common Stock Repurchased | (1K) | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 23K | (7K) | 1.48M | 3.35M | 0 |
| Financing Cash Flow | 111.88M | 7.49M | 23.98M | 55.87M | 10.52M |
| Effect of Forex Changes | (8K) | (9K) | 3K | (1K) | 5K |
| Net Change in Cash | 82.96M | (35.88M) | (15.63M) | 15.36M | (30.23M) |
| Free Cash Flow | (28.92M) | (43.36M) | (39.61M) | (40.51M) | (40.75M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$53.3M
+ D&A$756.0K
+ Stock-Based Comp$11.1M
+ Deferred Tax$0
+ Working Capital$1.0M
+ Other Non-Cash$327.0K
= Operating Cash Flow-$40.2M
- Capex-$580.0K
= Free Cash Flow-$40.8M
Analysis
FY2025 free cash flow is -$40.8M. FCF conversion is 76.4% of net income. Operating cash flow was -$40.2M, with capex of -$580.0K. The largest bridge item is Stock-Based Comp at $11.1M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Sep 21, 2026 | |
| SC 13D | SC 13D filing | Aug 24, 2026 | |
| SC 13G | SC 13G filing | Aug 14, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 13, 2026 |
Does CVRX generate free cash flow?
CVRx, Inc. (CVRX) generated -$40.75M of free cash flow in fiscal 2025.
How much operating cash flow does CVRX produce?
Operating cash flow was -$40.17M, before capital expenditures of $580,000.00.
Continue the stock analysis
Jump to another research area for this company.